Stock screenerAll disclosures →
EDGAR →
STRO
Conviction 64HealthcareScan · Thu, Jun 25, 2026STRO$29.89-0.47%
ResistanceSupportVol 14Vol MA14 269.98K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price29.89
Change-0.47%
Gap-1.37%
Rel volume1.14×
Avg volume270.75K
Avg $ vol7.64M
SMA 2028.16
SMA 5032.07
SMA 20015.96
Price vs 50-6.80%
Price vs 200+87.31%
MA stackmixed
50/200 cross—
Supertrenddown · 34.70
RSI (14)51
MACD hist0.49
MACD crossbull · 7d
Stoch %K / %D66 / 65
ADX (14)17
+DI / −DI18 / 19
RSI divergence—
MACD divergence—
ATR %+9.64%
ADR %9.70%
52w high40.91
52w low0.6800
From 52w high-26.94%
Above 52w low+4295.59%
New 52w highNo
SqueezeOff
Bollinger width26.36%
%B0.73
Donchian pos68.57%
Donchian high32.76
Donchian low23.63
AVWAP (52w high)29.47
vs AVWAP high+1.41%
AVWAP (52w low)7.08
vs AVWAP low+322.18%
OBV trendUp
Chaikin MF (20)-0.20
Today vs 20d1.14×
Avg vol (14d)269.98K
Avg vol (20d)270.75K
Avg $ vol (20d)7.64M
Market cap495.29M
RS 3m (vs SPY)+15.15%
RS 6m (vs SPY)+193.17%
RS line new highNo
Trend template6/8
Technical rank74.7
1 week+5.21%
1 month+9.17%
3 months+27.22%
6 months+188.24%
1 year+3534.48%
YTD+172.72%
P/E-2.59
P/B-7.40
P/S4.83
P/FCF-2.77
EPS-22.49
Div yield—
ROE285.68%
ROA-78.97%
Debt/Eq-0.06
Current3.12
EV/EBITDA-2.82
Gross margin—
Net margin-186.45%
Rev growth65.18%
EPS growth15.99%
Price target50.50
Target upside68.95%
Analyst ratingBuy
Institutional89.35%
Ent. value425.67M
Revenue14.52M
Net income-38.48M
Gross profit—
Free cash flow-178.79M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out16.57M
Employees133
ListedThu, Sep 27, 2018
Free float15.56M
Float %93.9%
Short interest751.37K
Days to cover1.7d
Short volume45.0%
Squeeze score24 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$2.05 · 5 est
Last EPS vs est−$2.94 vs −$2.32
Last surprise-26.7% miss
Setup gradeB
Conviction64 / 100
Pattern quality—
Tech rank74.7 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance42.87
Support24.01
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in STRO
No recent disclosed trades by Congress in STRO. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in STRO · 9 buys · 1 sell
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Hunter Heidi Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Petree Daniel H Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
MATSUI CONNIE Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Jagpal Sukhi Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
PANEK JAMES P Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Wigginton Jon Marc Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Dybbs Michael Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Lobacki Joseph M Director · Stock Option (right to buy) · 2026-06-05 | Grant | 10K | $0 | 2026-06-05 | 2026-06-09 |
Chow Gregory K. CFO · Restricted Stock Units (RSUs) · 2026-06-02 | Exercise | 2.5K | $0 | 2026-06-02 | 2026-06-02 |
Chow Gregory K. CFO · Common Stock · 2026-06-02 | Exercise | 2.5K | $0 | 2026-06-02 | 2026-06-02 |
SEC filings
EDGAR filings in STRO · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.